Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eric Marshall Knoche"'
Autor:
Martin W. Schoen, Ruth Douglas Etzioni, Eric Marshall Knoche, Julie N Graff, Kristen Marie Sanfilippo, Suhong Luo, Seth A Eisen, Robert Bruce Montgomery
Publikováno v:
Journal of Clinical Oncology. 41:87-87
87 Background: Combination therapies using the androgen deprivation therapy (ADT) backbone have revolutionized treatment of metastatic hormone sensitive prostate cancer (mHSPC). Combinations include ADT plus docetaxel (DOC) or the androgen receptor t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b5c54b1b979165a8372d95f8f2c6d6f
https://doi.org/10.1200/jco.2023.41.6_suppl.87
https://doi.org/10.1200/jco.2023.41.6_suppl.87
Autor:
Koral Shah, Aravinda Ganapathy, Ariel Borkowski, Nakul Shah, Dhruv Bansal, Rachel Beck, Eric Marshall Knoche, Joel Picus, Melissa Andrea Reimers, Bruce J. Roth, James L. Gulley, Robert Schreiber, Russell Kent Pachynski
Publikováno v:
Journal of Clinical Oncology. 40:5068-5068
5068 Background: Treatment with immune checkpoint blockade (ICB) alone results in suboptimal response rates in prostate cancer. Prostvac-VF Tricom is a therapeutic vaccine that incorporates DNA for the shared self-antigen PSA. Personalized neoantigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06b40b16a76209a44e08388e08fc3ba8
https://doi.org/10.1200/jco.2022.40.16_suppl.5068
https://doi.org/10.1200/jco.2022.40.16_suppl.5068
Autor:
Ruben Carmona, Alan Pollack, Zachary L Smith, Jeff M. Michalski, Hiram Alberto Gay, Gerald L. Andriole, Vivek Arora, Aadel A Chaudhuri, Eric Marshall Knoche, Russell Kent Pachynski, Joel Picus, Melissa Andrea Reimers, Bruce J. Roth, Paul Sargos, Mohamed S. Zaghloul, John Paul Christodouleas, Brian Christopher Baumann
Publikováno v:
Journal of Clinical Oncology. 39:490-490
490 Background: Integrating molecular subtypes, gene transcripts associated with disease recurrence (DR), and clinicopathologic features may help risk stratify muscle-invasive bladder cancer (MIBC) patients & guide therapy selection. We hypothesized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dccea47851ac5b01e13826a07f8d8472
https://doi.org/10.1200/jco.2021.39.6_suppl.490
https://doi.org/10.1200/jco.2021.39.6_suppl.490
Autor:
Benjamin Walker Fischer-Valuck, Jeff M. Michalski, John Paul Christodouleas, Eric Kim, Todd A. DeWees, Gerald L. Andriole, Vivek Arora, Ruben Carmona, Robert S. Figenshau, Robert L. Grubb, Thomas J. Guzzo, Eric Marshall Knoche, S. Bruce Malkowicz, Ronac Mamtani, Russell Kent Pachynski, Joel Picus, Sriram Venigalla, Bruce J. Roth, Hiram Alberto Gay, Brian Christopher Baumann
Publikováno v:
Journal of Clinical Oncology. 36:484-484
484 Background: Local-regional failure (LF) for locally advanced bladder cancer (LABC) after radical cystectomy (RC) is common even with chemo and is associated with high morbidity/mortality. Adjuvant radiotherapy (adjRT) can reduce LF and may enhanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e446681adcbd5e85be22793a0f66de2
https://doi.org/10.1200/jco.2018.36.6_suppl.484
https://doi.org/10.1200/jco.2018.36.6_suppl.484